Emergence of novel norovirus GII.4 variant

Abstract

We detected a novel GII.4 variant with an amino acid insertion at the start of epitope A in viral protein 1 of noroviruses from the United States, Gabon, South Africa, and the United Kingdom collected during 2017–2022. Early identification of GII.4 variants is crucial for assessing pandemic potential and informing vaccine development.

Description

Keywords

South Africa (SA), United Kingdom (UK), United States (US), Acute gastroenteritis, Enteric infections, Norovirus, Viruses

Sustainable Development Goals

SDG-03: Good health and well-being
SDG-09: Industry, innovation and infrastructure

Citation

Chhabra, P., Tully, D.C., Mans, J. et al. 2024, 'Emergence of novel norovirus GII.4 variant', Emerging Infectious Diseases, vol. 30, no. 1, pp. 163-167, doi : 10.3201/eid3001.231003.